Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RBFJO
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
alpha-cMET ADC-Duo5_P1 (lo DAR)
|
|||||
| Synonyms |
alpha-cMET ADC-Duo5_P1 (lo DAR)
Click to Show/Hide
|
|||||
| Organization |
Antibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USA.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0.8-1.1
|
|||||
| Structure |
|
|||||
| Antibody Name |
cMET A1-8 IgG Fab
|
Antibody Info | ||||
| Antigen Name |
Hepatocyte growth factor receptor (MET)
|
Antigen Info | ||||
| Payload Name |
Duo5
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||